Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product (Instruments, Kits & Reagents), By Type, By Application, By Method (Column-based, Magnetic Beads), By End-use, By Region, And Segment Forecasts, 2021 - 2028
Nucleic Acid Isolation And Purification Market Growth & Trends
The global nucleic acid isolation and purification market size is anticipated to reach USD 9.8 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.4% from 2021 to 2028. The growth can be primarily attributed to the technological advancements in molecular detection platforms. The technologies such as robotic liquid handling in automated DNA extraction systems, have improved the process flow. Such automation has streamlined all the tasks involved in various processes, such as DNA extraction from samples, serial dilution, and picking the desired gene of interest.
The outbreak of SARS-CoV-2 in late 2019 in China quickly translated into a global pandemic, which led to high demand for efficient and affordable diagnostic tests that could be carried out in non-clinical as well as clinical settings. This also led to high demand for nucleic acid extraction kits which in turn has led the key players to increase their manufacturing capabilities. For instance, in March 2020, QIAGEN announced the expansion of its production capacity in the U.S. and Europe to reach 20 million monthly patient tests by the end of 2020.
Moreover, rapid diagnosis, effective treatment options, and future prevention plans are essential in the management of COVID-19. The current race for the development of cost-effective, point-of-contact test kits and efficient laboratory methodologies for the detection of coronavirus infection has driven a new frontier of diagnostic innovation. The increase in adoption of PCR for SARS-CoV-2 detection by a wide range of commercial laboratories drives the market, as nucleic acid isolation and purification is an important step in the PCR workflow.
Nucleic Acid Isolation And Purification Market Report Highlights
- The kits and reagents segment accounted for the largest revenue share in 2020 owing to the rising number of research studies focused on understanding rare and common genome-based diseases
- The RNA isolation and purification segment holds the largest revenue share in 2020 due to its increasing use for the analysis of COVID samples
- The DNA isolation and purification segment is expected to witness the fastest growth rate owing to its use in a variety of molecular biology applications
- The magnetic beads segment accounted for the largest revenue share in 2020 and is expected to continue the trend owing to the advantage of obtaining the purest possible form of DNA/RNA and excluding other unwanted materials from the sample mixture
- The diagnostics segment dominated the market and accounted for the largest revenue share in 2020 owing to the high adoption of NAI and P products for detecting and characterizing microorganisms
- The pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to their increasing research and development activities for drug development
- North America has emerged as the highest revenue-generating region due to intensive research projects in the region for cancer detection and other chronic disorders
- Companies operating in the market are launching new and automated systems for nucleic acid isolation and purification. For instance, in March 2021, QIAGEN N.V. launched an automated sample processing system the QIAcube Connect MDx for molecular diagnostic laboratories
- The system helps in the automation of several steps such as lysis, binding, washing, and elution for RNA, DNA, and protein sample processing
Please note The report will be updated with the latest data and delivered to you within 2-3 business days.
- Chapter 1 Methodology and Scope
- 1.1 Research Scope
- 1.1.1 Estimates and Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.3.1 List of secondary data sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
- 1.3.5.1 Primary Interviews: Statistics
- 1.3.5.1.1 Geographical distribution of primary interviews
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Parent & ancillary techniques
- 1.7 Product Scope
- 1.7.1 Definition
- 1.7.1.1 Instruments
- 1.7.1.2 Kits & reagents
- 1.7.2 Market model
- 1.8 Type Scope
- 1.8.1 Definition
- 1.8.1.1 DNA isolation & purification
- 1.8.1.2 RNA isolation & purification
- 1.8.2 Market model
- 1.9 Method Scope
- 1.9.1 Definition
- 1.9.1.1 Column based
- 1.9.1.2 Magnetic bead based
- 1.9.1.3 Reagent based
- 1.9.1.4 Others
- 1.9.2 Market model
- 1.9.2.1 By method
- 1.10 Application Scope
- 1.10.1 Definition
- 1.10.1.1 Precision medicine
- 1.10.1.2 Diagnostics
- 1.10.1.3 Drug Discovery & Development
- 1.10.1.4 Agriculture and Animal Research
- 1.10.1.5 Other Applications
- 1.10.2 Market model
- 1.11 End-use Scope
- 1.11.1 Definition
- 1.11.1.1 Academic research institutes
- 1.11.1.2 Pharmaceutical & biotechnology companies
- 1.11.1.3 Contract research organizations
- 1.11.1.4 Hospitals and diagnostic centers
- 1.11.1.5 Other End-use
- 1.11.2 Market model
- 1.12 Regional Scope
- 1.12.1 Region-wise market: Base estimates
- 1.13 Objectives
- 1.13.1 Objective 1:
- 1.13.2 Objective 2:
- Chapter 2 Executive Summary
- 2.1 Nucleic Acid Isolation And Purification Market: Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
- 2.4 Market Summary
- Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent & ancillary market outlook
- 3.2 Nucleic Acid Isolation & Purification Market: Technology Trends
- 3.2.1 Technology trends
- 3.3 Outsourcing & contract manufacturing trends
- 3.4 Market Dynamics
- 3.4.1 Market driver analysis
- 3.4.1.1 Increasing incidence of cancer, genetic disorders, and infectious diseases
- 3.4.1.2 Increase in public-private funding on biotechnology and life sciences research
- 3.4.1.3 Advancements in automation
- 3.4.1.4 Growth in NGS technologies
- 3.4.1.5 Growing demand for genetically modified crops and organisms
- 3.4.2 Market restraint analysis
- 3.4.2.1 Expensive instruments and consequent low penetration in emerging countries
- 3.4.2.2 Challenges related to the use of big data and bioinformatics
- 3.4.3 Market opportunity analysis
- 3.4.3.1 Automation in nucleic acid isolation and purification techniques
- 3.4.3.2 Adoption of downstream applications of nucleic acid purification and isolation for COVID-19 diagnostics
- 3.4.4 Market challenge analysis
- 3.4.4.1 Challenges associated with sample preparation
- 3.5 Penetration & Growth Prospect Mapping for Method, 2020
- 3.6 COVID-19 Impact Analysis on Market
- 3.6.1 Utilization of nucleic acid isolation and purification kits for analysis of COVID-19 samples
- 3.6.2 Shortage of RNA isolation kits
- 3.6.3 Increase in global production capacities
- 3.7 BUSINESS ENVIRONMENT ANALYSIS
- 3.7.1 Nucleic Acid Isolation & Purification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
- 3.7.2 Porter’s Five Forces Analysis
- 3.8 Major Deals & Strategic Alliances Analysis
- 3.8.1 Product developments
- 3.8.2 Merger & acquisition
- 3.8.3 Agreement
- 3.8.4 Collaboration & partnership
- Chapter 4 Product Business Analysis
- 4.1 Nucleic Acid Isolation and Purification Market: Product Movement Analysis
- 4.2 Kits & Reagents
- 4.2.1 Kits & reagents market estimates and forecasts, 2017 - 2028 (USD Million)
- 4.3 Instruments
- 4.3.1 Instruments market estimates and forecasts, 2017 - 2028 (USD Million)
- Chapter 5 Type Business Analysis
- 5.1 Nucleic Acid Isolation and Purification Market: Type Movement Analysis
- 5.2 DNA Isolation & Purification
- 5.2.1 DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.2.2 Genomic DNA isolation & purification
- 5.2.2.1 Genomic DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.2.3 Plasmid DNA isolation & purification
- 5.2.3.1 Plasmid DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.2.4 Viral DNA isolation & purification
- 5.2.4.1 Viral DNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.2.5 Other types
- 5.2.5.1 Others market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.3 RNA Isolation & Purification
- 5.3.1 RNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.3.2 RNA Isolation Reagents and Instruments Market, By End Use
- 5.3.2.1 Manufacturing/bioprocessing
- 5.3.2.2 Research
- 5.3.2.3 Clinical/diagnostics
- 5.3.3 miRNA isolation and purification
- 5.3.3.1 miRNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.3.4 mRNA isolation & purification
- 5.3.4.1 mRNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.3.5 Total RNA isolation & purification
- 5.3.5.1 Total RNA isolation & purification market estimates and forecasts, 2017 - 2028 (USD Million)
- 5.3.6 Other types
- 5.3.6.1 Others market estimates and forecasts, 2017 - 2028 (USD Million)
- Chapter 6 Method Business Analysis
- 6.1 Nucleic Acid Isolation and Purification Market: Method Movement Analysis
- 6.2 Column Based Isolation & Purification
- 6.2.1 Column based market estimates and forecasts, 2017 - 2028 (USD Million)
- 6.3 Magnetic Bead Based Isolation & Purification
- 6.3.1 Magnetic beads market estimates and forecasts, 2017 - 2028 (USD Million)
- 6.4 Reagent Based Isolation & Purification
- 6.4.1 Reagent based market estimates and forecasts, 2017 - 2028 (USD Million)
- 6.5 Other Methods
- 6.5.1 Others market estimates and forecasts, 2017 - 2028 (USD Million)
- Chapter 7 Application Business Analysis
- 7.1 Nucleic Acid Isolation and Purification Market: Application Movement Analysis
- 7.2 Precision Medicine
- 7.2.1 Precision medicine market estimates and forecasts, 2017 - 2028 (USD Million)
- 7.3 Diagnostics
- 7.3.1 Diagnostics market estimates and forecasts, 2017 - 2028 (USD Million)
- 7.4 Drug Discovery & Development
- 7.4.1 Drug discovery & development market estimates and forecasts, 2017 - 2028 (USD Million)
- 7.5 Agriculture & Animal Research
- 7.5.1 Agriculture and animal research market estimates and forecasts, 2017 - 2028 (USD Million)
- 7.6 Other Applications
- 7.6.1 Other applications market estimates and forecasts, 2017 - 2028 (USD Million)
- Chapter 8 End-use Business Analysis
- 8.1 Nucleic Acid Isolation and Purification Market: End-use Movement Analysis
- 8.1.1 Application Scope: Test Type Penetration
- 8.2 Academic Research Institutes
- 8.2.1 Academic research institutes market estimates and forecasts, 2017 - 2028 (USD Million)
- 8.3 Pharmaceutical & Biotechnology Companies
- 8.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2017 - 2028 (USD Million)
- 8.4 Contract Research Organizations
- 8.4.1 Contract Research Organizations market estimates and forecasts, 2017 - 2028 (USD Million)
- 8.5 Hospitals and Diagnostic Centers
- 8.5.1 Hospitals and diagnostic centers market estimates and forecasts, 2017 - 2028 (USD Million)
- 8.6 Other End-use
- 8.6.1 Other end-use market estimates and forecasts, 2017 - 2028 (USD Million)
- Chapter 9 Regional Business Analysis
- 9.1 Nucleic Acid Isolation & Purification Market Share By Region, 2020 & 2028
- 9.2 North America
- 9.2.1 North America market estimates and forecasts, 2017 - 2028 (USD Million)
- 9.2.2 U.S.
- 9.2.2.1 U.S. nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.2.2.2 U.S. nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.2.2.3 U.S. nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.2.2.4 U.S. nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.2.2.5 U.S. nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.2.3 Canada
- 9.2.3.1 Canada nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.2.3.2 Canada nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.2.3.3 Canada nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.2.3.4 Canada nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.2.3.5 Canada nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.3 Europe
- 9.3.1 Europe market estimates and forecasts, 2017 - 2028 (USD Million)
- 9.3.2 Germany
- 9.3.2.1 Germany nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.3.2.2 Germany nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.3.2.3 Germany nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.3.2.4 Germany nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.3.2.5 Germany nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.3.3 U.K.
- 9.3.3.1 U.K. nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.3.3.2 U.K. nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.3.3.3 U.K. nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.3.3.4 U.K. nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.3.3.5 U.K. nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.4 Asia Pacific
- 9.4.1 Asia Pacific market estimates and forecasts, 2017 - 2028 (USD Million)
- 9.4.2 Japan
- 9.4.2.1 Japan nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.4.2.2 Japan nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.4.2.3 Japan nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.4.2.4 Japan nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.4.2.5 Japan nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.4.3 China
- 9.4.3.1 China nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.4.3.2 China nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.4.3.3 China nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.4.3.4 China nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.4.3.5 China nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.5 Latin America
- 9.5.1 Latin America market estimates and forecasts, 2017 - 2028 (USD Million)
- 9.5.2 Brazil
- 9.5.2.1 Brazil nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.5.2.2 Brazil nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.5.2.3 Brazil nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.5.2.4 Brazil nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.5.2.5 Brazil nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.5.3 Mexico
- 9.5.3.1 Mexico nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.5.3.2 Mexico nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.5.3.3 Mexico nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.5.3.4 Mexico nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.5.3.5 Mexico nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- 9.6 Middle East and Africa (MEA)
- 9.6.1 MEA market estimates and forecasts, 2017 - 2028 (USD Million)
- 9.6.2 South Africa
- 9.6.3.1 South Africa nucleic acid isolation & purification market, by product, 2017 - 2028 (USD Million)
- 9.6.3.2 South Africa nucleic acid isolation & purification market, by type, 2017 - 2028 (USD Million)
- 9.6.3.3 South Africa nucleic acid isolation & purification market, by method, 2017 - 2028 (USD Million)
- 9.6.3.4 South Africa nucleic acid isolation & purification market, by application, 2017 - 2028 (USD Million)
- 9.6.3.5 South Africa nucleic acid isolation & purification market, by end use, 2017 - 2028 (USD Million)
- Chapter 10 Competitive Landscape
- 10.1 Company categorization
- 10.2 Strategy framework
- 10.3 Competitive Landscape
- 10.4 Public Companies
- 10.4.1 Company size
- 10.4.2 Geographical presence
- 10.4.3 Product portfolio
- 10.4.4 Segment coverage
- 10.4.5 Other factors
- 10.5 Private Companies
- 10.5.1 List of key emerging companies
- 10.6 Company Profiles
- 10.6.1 QIAGEN
- 10.6.1.1 Company overview
- 10.6.1.2 Financial Performance
- 10.6.1.3 Product benchmarking
- 10.6.1.4 Strategic initiatives
- 10.6.2 Thermo Fisher Scientific, Inc.
- 10.6.2.1 Company overview
- 10.6.2.2 Financial Performance
- 10.6.2.3 Product benchmarking
- 10.6.2.4 Strategic initiatives
- 10.6.3 Illumina Inc
- 10.6.3.1 Company overview
- 10.6.3.1.1 Epicentre (An Illumina Company)
- 10.6.3.2 Financial performance
- 10.6.3.3 Product benchmarking
- 10.6.3.4 Strategic initiatives
- 10.6.4 Danaher Corporation
- 10.6.4.1 Company overview
- 10.6.4.1.1 Beckman Coulter, Inc.
- 10.6.4.1.2 Cytiva (formerly GE Healthcare)
- 10.6.4.2 Financial Performance
- 10.6.4.2.1 Financial Performance: Cytiva
- 10.6.4.3 Product benchmarking
- 10.6.4.4 Strategic initiatives
- 10.6.5 F. Hoffmann-La Roche Ltd.
- 10.6.5.1 Company overview
- 10.6.5.2 Financial Performance
- 10.6.5.3 Product benchmarking
- 10.6.5.4 Strategic initiatives
- 10.6.6 Merck KGaA
- 10.6.6.1 Company overview
- 10.6.6.1.1 Sigma-Aldrich Co. LLC
- 10.6.6.2 Financial Performance
- 10.6.6.3 Product benchmarking
- 10.6.6.4 Strategic initiatives
- 10.6.7 Agilent Technologies
- 10.6.7.1 Company overview
- 10.6.7.2 Financial Performance
- 10.6.7.3 Product benchmarking
- 10.6.7.4 Strategic initiatives
- 10.6.8 Bio-Rad Laboratories, Inc.
- 10.6.8.1 Company overview
- 10.6.8.2 Financial Performance
- 10.6.8.3 Product benchmarking
- 10.6.8.4 Strategic initiatives
- 10.6.9 TAKARA BIO, INC.
- 10.6.9.1 COMPANY OVERVIEW
- 10.6.9.1.1 Clontech Laboratories, Inc.
- 10.6.9.2 FINANCIAL PERFORMANCE
- 10.6.9.3 PRODUCT BENCHMARKING
- 10.6.9.4 STRATEGIC INITIATIVES
- 10.6.10 Promega Corporation
- 10.6.10.1 Company overview
- 10.6.10.2 Financial Performance
- 10.6.10.3 Product benchmarking
- 10.6.10.4 STRATEGIC INITIATIVES
- 10.6.11 New England Biolabs
- 10.6.11.1 Company overview
- 10.6.11.2 Financial Performance
- 10.6.11.3 Product benchmarking
- 10.6.11.4 Strategic initiatives
- 10.6.12 LGC Limited
- 10.6.12.1 Company overview
- 10.6.12.1.1 LGC Biosearch Technologies
- 10.6.12.2 Financial Performance
- 10.6.12.3 Product benchmarking
- 10.6.12.4 Strategic initiatives
- 10.6.13 Abcam plc
- 10.6.13.1 Company overview
- 10.6.13.2 Financial Performance
- 10.6.13.3 Product benchmarking
- 10.6.14 Norgen Biotek Corp.
- 10.6.14.1 Company overview
- 10.6.14.2 Product benchmarking
- 10.6.14.3 Strategic initiatives
- 10.6.15 AUTOGEN. INC.
- 10.6.15.1 Company overview
- 10.6.15.2 Financial Performance
- 10.6.15.3 Product benchmarking
- 10.6.15.4 Strategic initiatives
- 10.6.16 Biogenuix
- 10.6.16.1 Company overview
- 10.6.16.2 Product benchmarking
- 10.6.16.3 Strategic initiatives
- 10.6.17 PCR Biosystems, Inc.
- 10.6.17.1 Company overview
- 10.6.17.2 Financial Performance
- 10.6.17.3 Product benchmarking
- 10.6.17.4 Strategic initiatives
- 10.6.18 MagGenome
- 10.6.18.1 Company overview
- 10.6.18.2 Product benchmarking
- 10.6.18.3 Strategic initiatives
- 10.6.19 Axon Scientific Sdn. Bhd./ Apical Scientific Sdn. Bhd.
- 10.6.19.1 Company overview
- 10.6.19.2 Product benchmarking
- 10.6.20 MACHEREY-NAGEL GmbH & Co. KG
- 10.6.20.1 Company overview
- 10.6.20.2 Financial Performance
- 10.6.20.3 Product benchmarking
- 10.6.20.4 Strategic initiatives